Apports nutritionnels
Hence, in 2022, glucose-lowering efficacy and proven cardiovascular effects were important for the strong positioning of semaglutide, dulaglutide and tirzepatide in guidelines on the management of hyperglycaemia in type 2 diabetes [33], and a similar strong positioning of incretin therapy was seen in guidelines on primary care [39]
And state lawmakers agreed with him, restricting Medicaid coverage for GLP-1s only for those with Type 2 diabetes in the budget they approved and sent to the governors desk
Ulvik A, Vollset SE, Hansen S, Gislefoss R, Jellum E, Ueland PM
Factors such as your starting weight, commitment to lifestyle changes, medication dose, and overall health can all influence your results
Another limitation is the lack of instrumental evaluation of the liver, which did not allow us to confirm the diagnosis of NAFLD and its related liver complications